Center for Clinical and Translational Science

nual Lecture was delivered by two world renowned bioethical experts, Jeffrey Kahn PhD, MPH and Michael Parker, BEd, MA, PhD on September 6, 2023. Dr. Lederberg was a leader in research on the challenging bioethical issues affecting the care of cancer patients and the medical and nursing staff caring for cancer patients The Marguerite S. Lederberg Annual Lecture is a tribute to Dr. Lederberg’s pioneering bioethical research and her profound impact on countless trainees and colleagues.

Dr. Kahn is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics, and the Levi Professor of Bioethics and Public Policy.  He is also Professor in the Department of Health Policy and Management in the Johns Hopkins University Bloomberg School of Public Health.  His research interests include the ethics of research, ethics and public health, and ethics and emerging biomedical technologies.  Dr. Parker is the Professor of Bioethics and Director of the Ethox Centre, University of Oxford, and Director, Wellcome Centre for Ethics and Humanities.  He has chaired and served on many United Kingdom and International committees on regulation and governance of research ethics, ethical issues in global health research, and the ethical aspects of genomics.

Drs. Kahn and Parker’s primary objective is to collaborate with scientists, health professionals, and public health experts to identify, analyze, and endeavor to devise strategies for addressing the pragmatic ethical dilemmas that arise in their routine professional endeavors. Their presentation, Emerging Technologies, Emerging Infectious Diseases, and the Role of Bioethics, focused on the emergence of the profound ethical issues that arise in the course of research on global infectious diseases and, most importantly, the equitable distribution of crucial vaccines and medications. Together they lead the Oxford-Johns Hopkins Global Infectious Disease Ethics Collaborative (GLIDE), which aims to provide a flexible collaborative platform for identifying and analyzing ethical issues arising in infectious disease treatment, research, response, and preparedness, through the lens of global health ethics.

Drs. Sarah Schlesinger, Barry Coller, Michael Parker, Jeffrey Kahn, Clinical Scholars,
and members of the Lederberg Family